Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse

Gene Therapy

Volumn 6, Issue 9, 1999, Pages 1626-1633

  Natsume, A ^a   Mizuno, M ^a   Ryuke, Y ^a   Yoshida, J ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C57BL 6 mouse; Cationic liposome; Gene therapy; Glioma; Murine interferon gene

Indexed keywords

BETA GALACTOSIDASE; BETA INTERFERON; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL GROWTH; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; GLIOMA; GLIOMA CELL; GROWTH INHIBITION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PLASMID; PRIORITY JOURNAL;

ANIMALS; BRAIN NEOPLASMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIOMA; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; INTERFERON-BETA; LIPOSOMES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0032877813     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300990     Document Type: Article

References (23)

1. Yoshida J, Kobayashi T, Kageyama N. Multimodality treatment of malignant glioma: effect of chemotherapy with ACNU and immunotherapy with N-CWS. Neurol Med Chir 1984; 24: 19-26.
2. Muller H, Brock M, Ernest H. Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas. Clin Neurol Neurosurg 1985; 87: 167-171.
3. Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Med 1997; 3: 1354-1361.
4. Lundblad D, Lundgren E. Block of a glioma cell line in S by interferon. Int J Cancer 1981; 27: 749-754.
5. Cook AW, Carter WA, Nidzgorski F, Akhtar L. Human brain tumor-derived cell lines: growth rate reduced by human fibroblast interferon. Science 1983; 219: 881-883.
6. Yoshida J et al. Antitumor activity of interferon-β against malignant glioma in combination with chemotherapeutic agent of nitrosourea (ACNU). In: Cantell K, Schellekens H (eds). The Biology of the Interferon System. Martinus Nijhoff: Boston, 1986, pp 399-406.
7. Yoshida J, Kajita Y, Wakabayashi T, Sugita K. Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation. Acta Neurochir 1994; 127: 55-59.
8. Wells V, Mallucci L. Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2′, 5′-oligoadenylate synthetase expression. J Interferon Res 1988; 8: 793-802.
9. Larsson I et al. Interferon production in glia and glioma cell lines. Infect Immun 1978; 22: 786-789.
10. James D et al. Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors. Cancer Res 1991; 51: 1684-1688.
11. Mizuno M et al. Growth inhibition of glioma cells transfected with the human β-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 1990; 50: 7826-7829.
12. Mizuno M, Yoshida J, Sugita K, Yagi K. Growth inhibition of glioma cells of different cell lines by human interferon-β produced in the cells transfected with its gene by means of liposomes. J Clin Biochem Nutr 1990; 9: 73-77.
13. Yagi K et al. Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain. Biochem Mol Biol Int 1994; 32: 167-171.
14. Yoshida J, Mizuno M, Yagi K. Antitumor effect of endogenous human β-interferon on malignant glioma and augmentation of the effect by tumor necrosis facter-α. J Clin Biochem Nutr 1992; 12: 153-160.
15. Yoshida J, Mizuno M, Yagi K. Secretion of human β-interferon into the cystic fluid of glioma transfected with the interferon gene. J Clin Biochem Nutr 1991; 11: 123-128.
16. Mizuno M, Yoshida J. Effect of human interferon-β gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells. Cancer Immunol Immunother 1998; 47: 227-232.
17. Mori T et al. A consideration on pharmacokinetics of a new water-soluble anti-tumor nitrosourea, ACNU, in patients with malignant brain tumor. Brain Nerve 1979; 31: 601-606.
18. Takakura K et al. Effect of ACNU and radiotherapy on a malignant glioma. J Neurosurg 1986; 64: 53-57.
19. Yoshida J, Mizuno M, Yagi K. Cytotoxity of human β-interferon produced in human glioma cells transfected with its gene by means of liposomes. Biochem Int 1992; 28: 1055-1061.
20. von Hoegen P. Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytes. Immun Lett 1995; 47: 157-162.
21. Chamberlain RS et al. Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. Cancer Res 1996; 56: 2832-2836.
22. Kuroki M et al. Antitumor effect of recombinant murine interferon-beta against mouse malignant glioma. J Interferon Res 1987; 7: 301-311.
23. Watanabe Y, Kawade Y. Induction, production and purification of natural mouse IFN-α and -β. In: Clemens MJ, Morris AG, Gearing AJH (eds). Lymphokines and Interferons: A Practical Approach. IRL: Oxford, 1987, pp 1-14.